Brain metastasis are a rare but serious occurrence in approximately 1-2% of advanced breast cancer cases, necessitates a tailored approach. Yazid BELKACEMI highlights the different radiotherapy options in addressing this challenging complication.
Navigating the complexities of metastasis in breast cancer demands a specialized and multifaceted approach. As cancer cells traverse the bloodstream or lymphatic system to distant organs or tissues, addressing this challenge requires a multidisciplinary understanding. In this focused exploration, our experts illuminate key areas concerning bone, liver, thoracic, and brain metastases, shedding light on the intricacies of localized treatments.
Bone metastasis stands as the predominant type in metastatic breast cancer, constituting approximately 80% of cases. Nicolas AMORETTI, interventional Radiologist, Nice, France will discuss the interest of mini invasive procedures such as percutaneous vertebroplasty and the exiting potential of bioactive cement bringing immunotherapy locally.
Liver metastasis, while less frequent, remains a serious complication in advanced breast cancer. Rakesh RAI, Surgeon, Dubai, UAE, unravel the intricacies of surgical interventions, offering insights into the potential benefits and considerations in the management of liver metastasis.
Lung metastasis, occurring in 10-15% of advanced breast cancer cases, poses a significant challenge often resistant to conventional treatments. Shahabazali PATIL, interventional radiologist, Abu Dhabi, UAE, will elucidate the role of ablative techniques, showcasing their potential as alternative approaches in addressing this less common yet serious complication.
Brain metastasis are a rare but serious occurrence in approximately 1-2% of advanced breast cancer cases, necessitates a tailored approach. Yazid BELKACEMI, Oncologist and Radiotherapist, Creteil, France will highlighting the different radiotherapy options in addressing this challenging complication.
As we embark on this comprehensive exploration, the imperative of a multidisciplinary approach becomes evident. Collaborative efforts across specialties are indispensable in the quest to manage metastasis effectively and improve the overall prognosis for individuals grappling with advanced breast cancer.